Abstract:Background Tyrosine kinase Axl, member of the TAM family, is expressed by antigen presenting cells and behaves as a negative regulator of the inflammatory cascade. Inflammatory stimuli up-regulate Axl expression in bone-marrow-derived macrophages 1. Soluble (s) Axl, generated by ADAM10, is a potent decoy for the TAM-ligand Gas6 and can impair TAM axis activation in lupus 2. In rheumatoid arthritis (RA) dendritic cells, Axl is epigenetically down-regulated 3. Emerging evidence has emphasised the significant role of Axl/sAxl in the pathogenesis and progression of autoimmune diseases, but little is known about TAM expression and regulation within the rheumatoid synovium. Objectives We aimed to quantify Axl/ADAM10 in synovial tissue (ST) and sAxl/Gas6 in synovial fluid (SF) and to correlate Axl/sAxl expression with synovial inflammation and disease severity in RA patients. Methods ST/SF were sampled from early treatment-naïve RA patients undergoing ultrasound (US)-guided synovial biopsy of the most inflamed accessible joint. RA was diagnosed according to ACR/EULAR2010 criteria. The Krenn’s synovitis score of inflammation was determined by H and E. Immunohistochemistry (IHC) staining of CD3/CD20/CD138/CD68 allowed to define the synovial immune infiltrate. Axl/ADAM10/CD68 were assessed in ST by IHC/immunofluorescence (30 patients). sAxl/Gas6 were quantified in 17 SF by ELISA. Synovial gene expression data were obtained by next-generation sequencing (80 patients). Results Axl was predominantly expressed only by CD68-positive macrophages of the lining and co-localised with ADAM10. AXL synovial mRNA significantly negatively correlated with the Krenn’s score and with the degree of infiltration by B/T lymphocytes, plasma cells, and sub-lining macrophages, but not lining macrophages. In SF, sAxl positively correlated with Gas6 and was significantly more abundant in patients with highly inflamed synovitis and more active disease. AXL synovial gene expression showed strong negative correlation with indexes of disease severity, including ESR, CRP, DAS28, and US synovial thickening/power-doppler, and with the mRNA of pro-inflammatory cytokines, e.g. TNF and IL6. Conclusions Our data demonstrate that, despite the highly-inflamed environment characterising RA synovia, Axl expression is restricted to the synovial lining, where it can be cleaved and released into the synovial fluid by ADAM10. There, sAXL can bind Gas6 with high affinity, preventing its interaction with transmembrane functional TAM receptors. Raised levels of sAxl and down-regulated AXL mRNA expression correlate with highly inflamed synovitis and more severe disease. Defects in the TAM system could provide an original mechanistic explanation of the persistent inflammation in the RA joints, representing a novel therapeutic target exploitable to regain tissue homeostasis. References [1] Zagórska A, et al. Diversification of TAM receptor tyrosine kinase function. Nat Immunol2014. [2] Orme JJ, et al. Heightened Cleavage of Axl Receptor Tyrosine Kinase by ADAM metalloproteases may contribute to disease pathogenesis in SLE. Clinical Immunology2016. [3] Kurowska-Stolarska M, et al. MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis. Nat Commun. Nature Publishing Group 2017. Disclosure of Interest None declared

Loss of the receptor tyrosine kinase Axl leads to enhanced inflammation in the CNS and delayed removal of myelin debris during Experimental Autoimmune Encephalomyelitis

Anti-Axl antibody treatment reduces the severity of experimental autoimmune encephalomyelitis

AXL-Induced Autophagy mitigates experimental autoimmune encephalomyelitis by suppressing microglial inflammation via the PI3K/AKT/mTOR signaling pathway

Loss of Gas6 and Axl signaling results in extensive axonal damage, motor deficits, prolonged neuroinflammation, and less remyelination following cuprizone exposure

Genetic ablation of steroid receptor coactivator-3 promotes PPAR-β-mediated alternative activation of microglia in experimental autoimmune encephalomyelitis

Axl Alleviates Neuroinflammation and Delays Japanese Encephalitis Progression in Mice

AXL kinase-mediated astrocytic phagocytosis modulates outcomes of traumatic brain injury

Autophagy induced by AXL receptor tyrosine kinase alleviates acute liver injury via inhibition of NLRP3 inflammasome activation in mice

Recombinant Gas6 augments Axl and facilitates immune restoration in an intracerebral hemorrhage mouse model

Deficiency of IκB Kinase Β in Myeloid Cells Reduces Severity of Experimental Autoimmune Encephalomyelitis.

Mechanism of gut microbiota and Axl/SOCS3 in experimental autoimmune encephalomyelitis.

THU0061 Restricted axl synovial expression and increased cleavage of axl ectodomain correlate with highly inflamed synovitis and more severe rheumatoid arthritis

Axl signaling induces development of natural killer cells in vitro and in vivo

Role of C16, angiopoietin-1 and regeneration gene protein 2 in attenuating inflammation in an experimental rat model of autoimmune encephalomyelitis.

Exacerbation of experimental autoimmune encephalomyelitis in P2X7R-/- mice: evidence for loss of apoptotic activity in lymphocytes.

Axl alleviates DSS-induced colitis by preventing dysbiosis of gut microbiota

Astrocytes play a key role in EAE pathophysiology by orchestrating in the CNS the inflammatory response of resident and peripheral immune cells and by suppressing remyelination

Axl Deficiency Promotes the Neuroinvasion of Japanese Encephalitis Virus by Enhancing IL-1α Production from Pyroptotic Macrophages

Gas6 Induces Myelination through Anti-Inflammatory IL-10 and TGF-β Upregulation in White Matter and Glia

TLR9 dependent regulation of AXL expression impacts migration of autoreactive B cells

Therapeutic Efficacy of Suppressing the JAK/STAT Pathway in Multiple Models of Experimental Autoimmune Encephalomyelitis